Sustained nitric oxide synthesis contributes to immunopathology in ongoing myocarditis attributable to interleukin-10 disorders

被引:58
作者
Szalay, Gudrun [1 ]
Sauter, Martina [1 ]
Hald, Joachim [1 ]
Weinzierl, Andreas [1 ]
Kandolf, Reinhard [1 ]
Klingel, Karin [1 ]
机构
[1] Univ Tubingen Hosp, Dept Mol Pathol, Inst Pathol, D-72076 Tubingen, Germany
关键词
D O I
10.2353/ajpath.2006.060350
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Ongoing coxsackievirus B3 (CVB3) myocarditis is characterized by persistence of viral RNA and chronic inflammation primarily mediated by macrophages and T cells. Activated macrophages produce anti-viral effector molecules comprising reactive nitrogen intermediates; however, reactive nitrogen intermediates also contribute to host tissue damage. Controlled activation of macrophages depends on interferon (IFN)-gamma and interleukin (IL)-10. To evaluate mechanisms involved in CVB3-induced pathogenesis of myocarditis, we determined the relationship of inducible nitric-oxide synthase (NOS) mRNA expression with IFN-gamma and IL-10 secretion during CVB3 infection in different mouse strains. We found in susceptible A.BY/SnJ mice that develop ongoing myocarditis, a low and delayed IFN-gamma secretion and highly diminished IL-10 production compared with resistant C57BL/6 mice. Consequently, NOS mRNA synthesis was delayed but clearly prolonged in susceptible mice. IL-10 gene-deficient mice confirmed the regulatory role of IL-10 in the outcome of CVB3 myocarditis. These mice did not establish a persistent cardiac infection and revealed IFN-gamma secretion kinetics similar to resistant mice but showed a slightly elongated cardiac NOS mRNA expression resulting in extended myocarditis. We conclude that coordinated secretion of IFN-gamma and 11,10 is crucial for the effective resolution of CVB3 myocarditis. Moreover, lack of regulatory IL-10 leads to uncontrolled NOS mRNA production, thus contributing to ongoing myocardial injury.
引用
收藏
页码:2085 / 2093
页数:9
相关论文
共 39 条
[1]  
Badorff C, 2000, CIRCULATION, V102, P2276
[2]  
Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424
[3]   Nitric oxide and the immune response [J].
Bogdan, C .
NATURE IMMUNOLOGY, 2001, 2 (10) :907-916
[4]  
CAPOBIANCHI M R, 1991, Viral Immunology, V4, P103, DOI 10.1089/vim.1991.4.103
[5]  
CHOW LH, 1992, LAB INVEST, V66, P24
[6]   The antiviral response to gamma interferon [J].
Costa-Pereira, AP ;
Williams, TM ;
Strobl, B ;
Watling, D ;
Briscoe, J ;
Kerr, IM .
JOURNAL OF VIROLOGY, 2002, 76 (18) :9060-9068
[7]  
DEBELDER AJ, 1995, BRIT HEART J, V74, P426
[8]  
Eriksson U, 2001, CIRCULATION, V103, P18
[9]   IL-12 protects against coxsackievirus B3-induced myocarditis by increasing IFN-γ and macrophage and neutrophil populations in the heart [J].
Fairweather, D ;
Frisancho-Kiss, S ;
Yusung, SA ;
Barrett, MA ;
Davis, SE ;
Steele, RA ;
Gatewood, SJL ;
Rose, NR .
JOURNAL OF IMMUNOLOGY, 2005, 174 (01) :261-269
[10]   Interferon-γ protects against chronic viral myocarditis by reducing mast cell degranulation, fibrosis, and the profibrotic cytokines transforming growth factor-β1, interleukin-1β, and interleukin-4 in the heart [J].
Fairweather, D ;
Frisancho-Kiss, S ;
Yusung, SA ;
Barrett, MA ;
Davis, SE ;
Gatewood, SJL ;
Njoku, DB ;
Rose, NR .
AMERICAN JOURNAL OF PATHOLOGY, 2004, 165 (06) :1883-1894